Related Experiment Video
Updated: May 3, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Wild-type RAS: keeping mutant RAS in CHK
Theonie Anastassiadis1, Eric J Brown1
1Abramson Family Cancer Research Institute, Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104, USA.
Abstract:
Mutant RAS-driven tumorigenesis was thought for decades to arise independently of wild-type RAS isoforms, but recent evidence indicates wild-type isoforms are involved. In this issue of Cancer Cell, Grabocka and colleagues report how the loss of wild-type RAS alters oncogenic signaling and dampens the DNA-damage response, thereby affecting tumor progression and chemosensitivity.
Insights
Wild-type RAS isoforms play a crucial role in cancer development, contrary to previous beliefs. Their loss impacts oncogenic signaling and DNA repair, influencing tumor growth and response to chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Mutant RAS proteins are key drivers of tumorigenesis.
- Wild-type RAS isoforms were historically considered uninvolved in RAS-driven cancers.
- Emerging evidence suggests a role for wild-type RAS in cancer development.
Purpose of the Study:
- To investigate the role of wild-type RAS isoforms in mutant RAS-driven tumorigenesis.
- To understand how loss of wild-type RAS affects oncogenic signaling pathways.
- To determine the impact of wild-type RAS on DNA-damage response and chemosensitivity.
Main Methods:
- Analysis of oncogenic signaling pathways in the presence and absence of wild-type RAS.
- Assessment of DNA-damage response mechanisms.
- Evaluation of tumor progression and chemosensitivity in relevant models.
Main Results:
- Loss of wild-type RAS significantly alters oncogenic signaling.
- The DNA-damage response is dampened upon loss of wild-type RAS.
- Altered signaling and DNA repair impact tumor progression and chemosensitivity.
Conclusions:
- Wild-type RAS isoforms are involved in mutant RAS-driven tumorigenesis.
- Loss of wild-type RAS creates vulnerabilities in cancer cells.
- Understanding this interaction may reveal new therapeutic strategies for RAS-driven cancers.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades

